<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Ann Gen Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann Gen Psychiatry</journal-id>
<journal-title-group>
<journal-title>Annals of General Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="epub">1744-859X</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32411272</article-id>
<article-id pub-id-type="pmc">7211339</article-id>
<article-id pub-id-type="publisher-id">280</article-id>
<article-id pub-id-type="doi">10.1186/s12991-020-00280-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>How obsessive–compulsive and bipolar disorders meet each other? An integrative gene-based enrichment approach</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hamidian</surname>
<given-names>Sajedeh</given-names>
</name>
<address>
<email>Sajedeh.hamidian@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pourshahbaz</surname>
<given-names>Abbas</given-names>
</name>
<address>
<email>apourshahbaz@yahoo.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bozorgmehr</surname>
<given-names>Ali</given-names>
</name>
<address>
<email>bozorgmehr.a@iums.ac.ir</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ananloo</surname>
<given-names>Esmaeil Shahsavand</given-names>
</name>
<address>
<email>Esmaeilshahsavand@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dolatshahi</surname>
<given-names>Behrooz</given-names>
</name>
<address>
<email>dolatshahee@yahoo.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ohadi</surname>
<given-names>Mina</given-names>
</name>
<address>
<email>ohadi.mina@yahoo.com</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.472458.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0612 774X</institution-id><institution>Department of Clinical Psychology, </institution><institution>University of Social Welfare and Rehabilitation Sciences (USWR), </institution></institution-wrap>Tehran, Iran </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.411746.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 4911 7066</institution-id><institution>Iran Psychiatric Hospital, </institution><institution>Iran University of Medical Sciences (IUMS), </institution></institution-wrap>Tehran, Iran </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.411705.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0166 0922</institution-id><institution>Department of Psychosomatic, Imam Khomeini Hospital Complex, School of Medicine, </institution><institution>Tehran University of Medical Sciences (TUMS), </institution></institution-wrap>Tehran, Iran </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.472458.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0612 774X</institution-id><institution>Iranian Research Center on Aging, </institution><institution>University of Social Welfare and Rehabilitation Sciences (USWR), </institution></institution-wrap>Tehran, Iran </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>9</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>9</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>19</volume>
<elocation-id>31</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>3</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>4</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2020</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">The novel approaches to psychiatric classification assume that disorders, contrary to what was previously thought, are not completely separate phenomena. In this regard, in addition to symptom-based criteria, disturbances are also considered on the basis of lower level components. With this viewpoint, identifying common biochemical markers would be beneficial in adopting a comprehensive strategy for prevention, diagnosis and treatment.</p>
</sec>
<sec>
<title>Main body</title>
<p id="Par2">One of the problematic areas in clinical settings is the coexistence of both obsessive–compulsive disorder (OCD) and bipolar disorder (BD) that is challenging and difficult to manage. In this study, using a system biologic approach we aimed to assess the interconnectedness of OCD and BD at different levels. Gene Set Enrichment Analysis (GSEA) method was used to identify the shared biological network between the two disorders. The results of the analysis revealed 34 common genes between the two disorders, the most important of which were <italic>CACNA1C</italic>, <italic>GRIA1</italic>, <italic>DRD2</italic>, <italic>NOS1</italic>, <italic>SLC18A1</italic>, <italic>HTR2A</italic> and <italic>DRD1</italic>. Dopaminergic synapse and cAMP signaling pathway as the pathways, dopamine binding and dopamine neurotransmitter receptor activity as the molecular functions, dendrite and axon part as the cellular component and cortex and striatum as the brain regions were the most significant commonalities.</p>
</sec>
<sec>
<title>Short conclusion</title>
<p id="Par3">The results of this study highlight the role of multiple systems, especially the dopaminergic system in linking OCD and BD. The results can be used to estimate the disease course, prognosis, and treatment choice, particularly in the cases of comorbidity. Such perspectives, going beyond symptomatic level, help to identify common endophenotypes between the disorders and provide diagnostic and therapeutic approaches based on biological in addition to the symptomatic level.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Enrichment analysis</kwd>
<kwd>Psychiatric genetic</kwd>
<kwd>Obsessive–compulsive disorder</kwd>
<kwd>Bipolar disorder</kwd>
<kwd>Genetic network</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par11">Obsessive–compulsive disorder (OCD), a devastating neuropsychiatric disorder with a strong genetic basis, affects 1–3% of the general population [<xref ref-type="bibr" rid="CR1">1</xref>]. OCD is mainly characterized by repetitive, intrusive thoughts, images and impulses called obsessions and repetitive ritualistic behaviors, called compulsions [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. A great number of patients with OCD experience cyclical courses manifested by episodes of recurrence and remission [<xref ref-type="bibr" rid="CR4">4</xref>]. This sinusoid phenomenon somewhat resembles the course of bipolar disorder (BD), another chronic psychiatric situation with cyclical episodes of mania and depression. Studies have provided evidence that there is a high rate of comorbidity between the two disorders. For instance, BD is reported to be diagnosed in 12–23% of clinical patients with OCD [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Remarkably, D’Ambrosio et al. have found that cyclothymia is the dominant temperament in 54% of patients with OCD [<xref ref-type="bibr" rid="CR7">7</xref>]. On the other hand, 21–35% of patients diagnosed with BD are reported to manifest OCD core symptoms [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
<p id="Par12">Although in terms of Feinstein thesis, comorbidity is defined as the co-existence of diagnostic criteria of two or more disorders in one subject [<xref ref-type="bibr" rid="CR9">9</xref>], the relationship between OCD and BD is beyond this simple definition. The co-occurring symptoms of the two disorders initially attracted clinicians’ attention [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. It was then observed that OCD and BD comorbidity is often accompanied by other conditions such as post-traumatic stress disorder (PTSD), eating disorder agoraphobia, panic disorder, earlier age of onset and a greater number of major depressive episodes [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Besides, major psychiatric disorders are very debilitating, as Ghio et al. have showed in major depressive disorder (MDD), early diagnosis and treatment can significantly reduce the unfavorable outcomes including disability of the disorder [<xref ref-type="bibr" rid="CR12">12</xref>]. Thus identifying the paths towards them are essential for early and timely treatment [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
<p id="Par13">Moreover, the evidence suggests a high rate of co-inheritance of the two disorders. For example, families of patients with OCD have a higher prevalence rate of BD than the controls [<xref ref-type="bibr" rid="CR14">14</xref>] and BD patients with family history of mood disorders had a significantly higher lifetime prevalence of OCD [<xref ref-type="bibr" rid="CR15">15</xref>]. Additionally, having OCD is reported to increase the risk of BD 13-fold greater than not having OCD [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
<p id="Par14">Although the two disorders do not share much at the phenotypic and behavioral levels, common endophenotypes have tightened the link between them. For example, both patients with BD and OCD showed impaired performance in verbal episodic memory mediated by semantic clustering abilities [<xref ref-type="bibr" rid="CR17">17</xref>]. Deficient response inhibition and sustained attention are the other cognitive endophenotypes observed in both patients with OCD [<xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR20">20</xref>] and BD [<xref ref-type="bibr" rid="CR21">21</xref>]. Furthermore, Benatti et al. reported significantly higher impulsivity levels in OCD patients compared to the controls [<xref ref-type="bibr" rid="CR22">22</xref>], whereas, impulsivity is a well-known criterion for predicting manic episodes and onset of BD [<xref ref-type="bibr" rid="CR23">23</xref>]. This moderately heritable component remains elevated during euthymia in BD and has been found among relatives of BD patients as well [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Adida et al. reported a trait-related impairment in decision-making in patients with BD compared to the healthy controls [<xref ref-type="bibr" rid="CR26">26</xref>], while the addiction model emphasizes on risky decision-making behaviors in the psychopathology of OCD [<xref ref-type="bibr" rid="CR27">27</xref>].</p>
<p id="Par15">At the anatomical level, the brain regions involved in BD and OCD are highly overlapped. While hypo-activity in the orbitofrontal cortex (OFC) and dorsolateral prefrontal cortex (DLPFC) is suggested to be associated with manic episodes [<xref ref-type="bibr" rid="CR28">28</xref>], parallel studies have demonstrated hyperactivity in the mentioned regions in patients with OCD as well [<xref ref-type="bibr" rid="CR29">29</xref>]. Furthermore, anterior cingulate cortex (ACC) and striatum are the other shared brain regions involved in the pathophysiology of both disorders [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>].</p>
<p id="Par16">More recently, genome-wide association studies (GWASs) and a significant number of confirmative candidate gene association studies, have identified shared loci for BD and OCD [<xref ref-type="bibr" rid="CR32">32</xref>–<xref ref-type="bibr" rid="CR35">35</xref>]. In a recent study, O’Connell et al. reported common genetic etiology for schizophrenia (SCZ), BD, autism spectrum disorders (ASD) and OCD. They suggested more researches on cross-disorder shared components in order to obtain translatable results for more specified clinical applications, prognosis and treatment management in mental health settings [<xref ref-type="bibr" rid="CR36">36</xref>].</p>
<p id="Par17">Although BD and OCD are phenotypically recognized as two distinct disorders, studies have reported high comorbidity of them. Existing theories have had little success in explaining the causes of this comorbidity phenotypically and sometimes they contradict each other; hence, we hypothesized that this comorbidity is rooted in the genetic similarities between the two disorders. Based on our knowledge, it seems that there is no comprehensive and integrative study on the shared genetic basis of OCD and BD yet. Therefore, the aim of the present study was to employ an exploratory approach to characterize the shared genetic basis of BD and OCD using a gene set-based approach following by molecular, cellular and pathway enrichment analyses. We assume that the OCD may share common genetic etiological factors and biological processes with BD.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Gene finding</title>
<p id="Par18">In order to obtain genes significantly associated with OCD and BD, we searched the PubMed and Google Scholar databases manually, using related keywords. The keywords were combination of: “bipolar disorder”, “BD”, “manic-depressive disorder”, “bipolar”, “mania”, “obsessive–compulsive disorder”, “OCD”, “gene”, “association”, “linkage”, “meta-analysis”, “genome-wide association study”, “genome-wide”, “GWAS”, “exome wide” and “polymorphism”. The genes retrieved from human structural genetic studies, and the genetic database for OCD [<xref ref-type="bibr" rid="CR37">37</xref>].</p>
<p id="Par19">Studies that had found genes associated with OCD symptoms, manic phases without BD diagnosis, some common features in the two disorders such as suicidal behavior, as well as gene expression studies were excluded. Association structural genetic studies were included regardless of age, ethnicity and gender of the evaluated individuals and also regardless of the published year. Linkage studies were included provided that the name of the gene was mentioned in the intended loci and the found marker was at the maximum distance equal to 500 base pair from the mentioned gene. In order to prevent the repetition of genes with different names, the Ensembl ID of each gene was obtained through Ensembl genome browser 92. Finally, a list of 397 BD genes and 148 OCD genes were achieved. Fifty-eight genes were shared between the two disorders and were considered for further analysis. The final list of included genes is presented in Additional file <xref ref-type="media" rid="MOESM1">1</xref>.</p>
</sec>
<sec id="Sec4">
<title>Gene Set Enrichment Analysis</title>
<p id="Par20">Gene Set Enrichment Analysis (GSEA) is a powerful method for interpreting the biological meaning of a list of genes or proteins that provide important insights into the biological mechanisms underlying that gene set. This method uses the proportion-based statistical approaches to identify certain molecular functions, cellular components or biological processes which are over- or under-represented within the lists of interest.</p>
<p id="Par21">We used WebGestalt (WEB-based Gene SeT AnaLysis Toolkit) for the gene set enrichment analysis. WebGestalt supports three well-established methods for enrichment analysis, including Over-Representation Analysis (ORA), Gene Set Enrichment Analysis (GSEA), and Network Topology-based Analysis (NTA). It incorporates information from different public resources and provides an easy way to make sense out of gene lists. In our analysis, we used ORA method for pathway enrichment analysis (based on the KEGG database [<xref ref-type="bibr" rid="CR38">38</xref>]), and molecular functions and cellular component enrichment analysis (based on the Gene Ontology [GO]) Consortium database: (<ext-link ext-link-type="uri" xlink:href="http://www.geneontology.org/">http://www.geneontology.org/</ext-link>) [<xref ref-type="bibr" rid="CR39">39</xref>]. Moreover, Cell Type-Specific Expression Analysis (CSEA) tool was used for identifying candidate circuits and regions, by using a list of genes that have the most expression in their cells (<ext-link ext-link-type="uri" xlink:href="http://genetics.wustl.edu/jdlab/csea-tool-2/">http://genetics.wustl.edu/jdlab/csea-tool-2/</ext-link>).</p>
<p id="Par22">The resulting data provided by enrichment analysis was analyzed and visualized using Cytoscape v3.6.0. Cytoscape is an open source software platform for complex molecular interaction network visualization and data integration. Using Network Analyzer toolbox for Cytoscape, a broad set of network topological parameters (number of nodes, edges and connected components, betweenness centrality and closeness centrality) were created. In the present diagram, the sizes of the nodes are based on betweenness centrality. Betweenness centrality is a measure of centrality in a graph based on shortest paths that measures the extent to which a vertex lies on paths between other vertices.</p>
</sec>
</sec>
<sec id="Sec5">
<title>Results</title>
<p id="Par23">The reconstructed interactive network consisted of 62 nodes and 128 edges, including 34 genes, 10 molecular functions, 7 pathways, 8 cellular components and 3 brain regions. On average, each gene was involved in 4 molecular functions, 5 pathways, 5 cellular components, and 3 brain regions (Fig. <xref ref-type="fig" rid="Fig1">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>The analyzed network of features involved in the pathogenesis of both OCD and BD. The yellow circles represent the genes, green diamonds the molecular functions, blue squares the cellular components, red hexagons the pathways and violet triangles represent brain regions. The larger the nodes, the bigger the betweenness centrality</p></caption><graphic id="MO1" xlink:href="12991_2020_280_Fig1_HTML"></graphic></fig></p>
<p id="Par24">Topological analysis of the network demonstrated that the majority of the nodes have the centrality between 0 and 0.1 (Fig. <xref ref-type="fig" rid="Fig2">2</xref>a). Furthermore, it was found that the majority of the nodes have a degree of connection between 1 and 2 (Fig. <xref ref-type="fig" rid="Fig2">2</xref>b).<fig id="Fig2"><label>Fig. 2</label><caption><p>Topological characteristics of the reconstructed network. <bold>a</bold> Betweenness centrality distribution of the nodes in the network. <bold>b</bold> Node degree distribution in the network</p></caption><graphic id="MO2" xlink:href="12991_2020_280_Fig2_HTML"></graphic></fig></p>
<p id="Par25"><italic>CACNA1C</italic>, <italic>GRIA1</italic>, <italic>DRD2</italic>, <italic>NOS1</italic>, <italic>SLC18A1</italic>, <italic>HTR2A</italic> and <italic>GRIK2</italic> were the most central genes in the network, respectively. The other central genes in the network are shown in Table <xref ref-type="table" rid="Tab1">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>The results of enrichment analysis for genes involved in the pathogenesis of both OCD and BD</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"></th><th align="left">Gene full official name</th><th align="left">HGNC symbol</th><th align="left">Betweenness centrality</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">Calcium voltage-gated channel subunit alpha1 C</td><td align="left">CACNA1C</td><td align="left">0.338153</td></tr><tr><td align="left">2</td><td align="left">Glutamate ionotropic receptor AMPA-type subunit 1 </td><td align="left">GRIA1</td><td align="left">0.1574122</td></tr><tr><td align="left">3</td><td align="left">Dopamine receptor D2</td><td align="left">DRD2</td><td align="left">0.1136524</td></tr><tr><td align="left">4</td><td align="left">Nitric oxide synthase 1</td><td align="left">NOS1</td><td align="left">0.0903783</td></tr><tr><td align="left">5</td><td align="left">Solute carrier family 18 member A1</td><td align="left">SLC18A1</td><td align="left">0.0661232</td></tr><tr><td align="left">6</td><td align="left">5-Hydroxytryptamine receptor 2A</td><td align="left">HTR2A</td><td align="left">0.0660831</td></tr><tr><td align="left">7</td><td align="left">Dopamine receptor D1</td><td align="left">DRD1</td><td align="left">0.0500920</td></tr><tr><td align="left">8</td><td align="left">Glutamate ionotropic receptor kainate-type subunit 2</td><td align="left">GRIK2</td><td align="left">0.0481045</td></tr><tr><td align="left">9</td><td align="left">Dopamine receptor D5</td><td align="left">DRD5</td><td align="left">0.0458659</td></tr><tr><td align="left">10</td><td align="left">5-Hydroxytryptamine receptor 1A, serotonin receptor</td><td align="left">HTR1A</td><td align="left">0.0443705</td></tr><tr><td align="left">11</td><td align="left">Glutamate ionotropic receptor NMDA-type subunit 2B</td><td align="left">GRIN2B</td><td align="left">0.036738</td></tr><tr><td align="left">12</td><td align="left">Solute carrier family 6 member 4</td><td align="left">SLC6A4</td><td align="left">0.020317</td></tr><tr><td align="left">13</td><td align="left">Glutamate ionotropic receptor kainate-type subunit 3</td><td align="left">GRIK3</td><td align="left">0.038491</td></tr><tr><td align="left">14</td><td align="left">Dopamine receptor D3</td><td align="left">DRD3</td><td align="left">0.017168</td></tr><tr><td align="left">15</td><td align="left">Cannabinoid receptor 1</td><td align="left">CNR1</td><td align="left">0.007217</td></tr><tr><td align="left">16</td><td align="left">Adrenoceptor alpha 1A</td><td align="left">ADRA1A</td><td align="left">0.006255</td></tr><tr><td align="left">17</td><td align="left">Brain-derived neurotrophic factor</td><td align="left">BDNF</td><td align="left">0.005617</td></tr><tr><td align="left">18</td><td align="left">Tryptophan hydroxylase 2</td><td align="left">TPH2</td><td align="left">0.0045508</td></tr><tr><td align="left">19</td><td align="left">Dopamine receptor D4</td><td align="left">DRD4</td><td align="left">0.004232</td></tr><tr><td align="left">20</td><td align="left">Glutamate decarboxylase 1</td><td align="left">GAD1</td><td align="left">0.003155</td></tr><tr><td align="left">21</td><td align="left">Gamma-aminobutyric acid type A receptor alpha1 subunit </td><td align="left">GABRA1</td><td align="left">0.001786</td></tr><tr><td align="left">22</td><td align="left">Neurotrophic receptor tyrosine kinase 2</td><td align="left">NTRK2</td><td align="left">0.001023</td></tr><tr><td align="left">23</td><td align="left">Angiotensin I converting enzyme</td><td align="left">ACE</td><td align="left">0</td></tr><tr><td align="left">24</td><td align="left">Ataxin 1</td><td align="left">ATXN1</td><td align="left">0</td></tr><tr><td align="left">25</td><td align="left">Cholinergic receptor nicotinic alpha 7 subunit</td><td align="left">CHRNA7</td><td align="left">0</td></tr><tr><td align="left">26</td><td align="left">Corticotropin-releasing hormone receptor 2</td><td align="left">CRHR2</td><td align="left">0</td></tr><tr><td align="left">27</td><td align="left">Dopamine beta-hydroxylase</td><td align="left">DBH</td><td align="left">0</td></tr><tr><td align="left">28</td><td align="left">Ephrin A5</td><td align="left">EFNA5</td><td align="left">0</td></tr><tr><td align="left">29</td><td align="left">Glutamic acid decarboxylase 2</td><td align="left">GAD2</td><td align="left">0</td></tr><tr><td align="left">30</td><td align="left">Glutamate ionotropic receptor NMDA-type subunit 2A</td><td align="left">GRIN2A</td><td align="left">0</td></tr><tr><td align="left">31</td><td align="left">5-Hydroxytryptamine receptor 2C</td><td align="left">HTR2C</td><td align="left">0</td></tr><tr><td align="left">32</td><td align="left">5-Hydroxytryptamine receptor 3A</td><td align="left">HTR3A</td><td align="left">0</td></tr><tr><td align="left">33</td><td align="left">Olfactomedin 1</td><td align="left">OLFM1</td><td align="left">0</td></tr><tr><td align="left">34</td><td align="left">Tumor necrosis factor</td><td align="left">TNF</td><td align="left">0</td></tr></tbody></table></table-wrap></p>
<p id="Par26">Among the pathways found through enrichment analysis, the dopaminergic synapse (Bc = 0.13604918, FDR = 3.86E−08), cAMP signaling pathway (Bc = 0.12989786, FDR = 1.19E−06) and serotonergic synapse (Bc = 0.0838125, FDR = 0.000112) were the nodes with the highest centrality involved in both OCD and BD. The most central molecular functions were dopamine binding (Bc = 0.011851, FDR = 3.59E−10), dopamine receptor activity (Bc = 0.0047987, FDR = 9.72E−09), glutamate-gated ion channel (Bc = 0, FDR = 2.06E−06) and G-protein-coupled amine receptor (Bc = 0.00705387, FDR = 0.000142), respectively. Cellular component enrichment analysis indicated that dendrites (Bc = 0.07980464, FDR = 0.000151) and axon parts (Bc = 0.03089599, FDR = 0.000215) are the main components involved in the pathology of OCD and BD. Finally, it was found that cortex (Bc = 0.22937063, FDR = 0.008), striatum (Bc = 0.1299988, FDR = 0.008) and hippocampus (Bc = 0.07421981, FDR = 0.008) are the main brain regions whose impairments contribute to the pathophysiology of OCD and BD. The other pathways, molecular functions and cellular components are shown in Table <xref ref-type="table" rid="Tab2">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>The results of enrichment analysis for pathways, molecular functions, cellular components and brain regions involved in the pathogenesis of both OCD and BD</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"></th><th align="left">Pathway full name</th><th align="left">KEGG ID</th><th align="left">FDR</th><th align="left">Betweenness centrality</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">Dopaminergic synapse</td><td align="left">hsa04728</td><td align="char" char=".">3.86E−08</td><td align="char" char=".">0.13604918</td></tr><tr><td align="left">2</td><td align="left">cAMP signaling pathway</td><td align="left">hsa04024</td><td align="char" char=".">1.19E−06</td><td align="char" char=".">0.12989786</td></tr><tr><td align="left">3</td><td align="left">Serotonergic synapse</td><td align="left">hsa04726</td><td align="char" char=".">0.000112</td><td align="char" char=".">0.0838125</td></tr><tr><td align="left">4</td><td align="left">Calcium signaling pathway</td><td align="left">hsa04020</td><td align="char" char=".">0.000979</td><td align="char" char=".">0.07812904</td></tr><tr><td align="left">5</td><td align="left">Glutamatergic synapse</td><td align="left">hsa04724</td><td align="char" char=".">0.001158</td><td align="char" char=".">0.04450784</td></tr><tr><td align="left">6</td><td align="left">GABAergic synapse</td><td align="left">hsa04727</td><td align="char" char=".">0.005543</td><td align="char" char=".">0.03118593</td></tr><tr><td align="left">7</td><td align="left">Retrograde endocannabinoid signaling</td><td align="left">hsa04723</td><td align="char" char=".">0.00753</td><td align="char" char=".">0.04801305</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left"></th><th align="left">Molecular functions</th><th align="left">Gene ontology (GO) ID</th><th align="left">FDR</th><th align="left">Betweenness centrality</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">Dopamine binding</td><td align="left">GO:0035240</td><td align="char" char=".">3.59E−10</td><td align="left">0.011851</td></tr><tr><td align="left">2</td><td align="left">Dopamine neurotransmitter receptor activity, coupled via Gs</td><td align="left">GO:0001588</td><td align="char" char=".">9.72E−09</td><td align="left">0.0047987</td></tr><tr><td align="left">3</td><td align="left">Extracellular-glutamate-gated ion channel activity</td><td align="left">GO:0005234</td><td align="char" char=".">2.06E−06</td><td align="left">0</td></tr><tr><td align="left">4</td><td align="left">G-protein-coupled amine receptor activity</td><td align="left">GO:0008227</td><td align="char" char=".">0.000142</td><td align="left">0.00705387</td></tr><tr><td align="left">5</td><td align="left">Amino acid binding</td><td align="left">GO:0016597</td><td align="char" char=".">0.000211</td><td align="left">0.02687112</td></tr><tr><td align="left">6</td><td align="left">Kainate-selective glutamate receptor activity</td><td align="left">GO:0015277</td><td align="char" char=".">0.001517</td><td align="left">0</td></tr><tr><td align="left">7</td><td align="left">Monoamine transmembrane transporter activity</td><td align="left">GO:0008504</td><td align="char" char=".">0.004829</td><td align="left">0.00237254</td></tr><tr><td align="left">8</td><td align="left">Serotonin binding</td><td align="left">GO:0051378</td><td align="char" char=".">0.004829</td><td align="left">5.53E−04</td></tr><tr><td align="left">9</td><td align="left">Ammonium transmembrane transporter activity</td><td align="left">GO:0008519</td><td align="char" char=".">0.028746</td><td align="left">0.00237254</td></tr><tr><td align="left">10</td><td align="left">Serotonin receptor activity</td><td align="left">GO:0099589</td><td align="char" char=".">0.028746</td><td align="left">5.53E−04</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left"></th><th align="left">Cellular components</th><th align="left">Gene ontology (GO) ID</th><th align="left">FDR</th><th align="left">Betweenness centrality</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">Dendrite</td><td align="left">GO:0030425</td><td align="char" char=".">0.000151</td><td align="char" char=".">0.07980464</td></tr><tr><td align="left">2</td><td align="left">Axon part</td><td align="left">GO:0033267</td><td align="char" char=".">0.000215</td><td align="char" char=".">0.03089599</td></tr><tr><td align="left">3</td><td align="left">Postsynaptic density</td><td align="left">GO:0014069</td><td align="char" char=".">0.000243</td><td align="char" char=".">0.05051219</td></tr><tr><td align="left">4</td><td align="left">Ionotropic glutamate receptor complex</td><td align="left">GO:0008328</td><td align="char" char=".">0.001148</td><td align="char" char=".">0.0055914</td></tr><tr><td align="left">5</td><td align="left">Membrane raft</td><td align="left">GO:0045121</td><td align="char" char=".">0.001158</td><td align="char" char=".">0.05504978</td></tr><tr><td align="left">6</td><td align="left">Cation channel complex</td><td align="left">GO:0034703</td><td align="char" char=".">0.003335</td><td align="char" char=".">0.02751275</td></tr><tr><td align="left">7</td><td align="left">Perikaryon</td><td align="left">GO:0043204</td><td align="char" char=".">0.01023</td><td align="char" char=".">0.00847745</td></tr><tr><td align="left">8</td><td align="left">Synaptic vesicle</td><td align="left">GO:0008021</td><td align="char" char=".">0.013692</td><td align="char" char=".">0.01103456</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left"></th><th align="left">Brain regions</th><th align="left"></th><th align="left">FDR</th><th align="left">Betweenness centrality</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">Cortex</td><td align="left"></td><td align="char" char=".">0.008</td><td align="char" char=".">0.22937063</td></tr><tr><td align="left">2</td><td align="left">Striatum</td><td align="left"></td><td align="char" char=".">0.008</td><td align="char" char=".">0.1299988</td></tr><tr><td align="left">3</td><td align="left">Hippocampus</td><td align="left"></td><td align="char" char=".">0.008</td><td align="char" char=".">0.07421981</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="Sec6">
<title>Discussion</title>
<p id="Par27">The results of enrichment analysis in the present study showed that the genes involved in glutamatergic transmission (<italic>GRIK2</italic>, <italic>GRIK3</italic>, <italic>GRIN2B</italic>, and <italic>GRIA1</italic>), dopaminergic transmission (<italic>DRD1</italic>, <italic>DRD2</italic>, <italic>DRD3</italic>, <italic>DRD4</italic>, and <italic>DRD5</italic>), serotonergic transmission (<italic>SLC6A4</italic>, <italic>HTR1A</italic>, <italic>HTR2A</italic>, and <italic>TPH2</italic>) and GABAergic transmission <italic>(GABBR2</italic>, <italic>GABA</italic>, and <italic>GAD1</italic>) are the most important genes associated with both the disorders.</p>
<p id="Par28">The calcium voltage-gated channel subunit alpha1 C; <italic>CACNA1C</italic> was found as the most central shared gene. The L-type voltage-gated calcium channel family include four different isoforms consisting of Cav1.1, Cav1.2, Cav1.3, and Cav1.4. CACNA1C codes for the α1C subunit of the Cav1.2 channel is involved in the proper functioning of the hippocampus, amygdala, and mesolimbic reward system circuits, which are strongly implicated in the pathophysiology of psychiatric disorders [<xref ref-type="bibr" rid="CR40">40</xref>]. While the most statistically robust CACNA1C associations are in BD, polymorphisms in CACNA1C shown to be correlated with other conditions such as schizophrenia, major depressive disorder (MDD), anxiety [<xref ref-type="bibr" rid="CR41">41</xref>], neuroticism and obsessive–compulsive thoughts [<xref ref-type="bibr" rid="CR40">40</xref>].</p>
<p id="Par29">The function of <italic>CACNA1C</italic> gene predicts amygdala and hippocampal activity during emotional processing and hippocampal activation during episodic and working memory recall [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], actions which are suggested as the main diagnostic intermediate phenotypes for both BD and OCD [<xref ref-type="bibr" rid="CR17">17</xref>]. In humans, <italic>CACNA1C</italic> risk variant modulates an individual’s inclination to respond to reward. The mesolimbic–dopamine system, through the ventral tegmental area (VTA)–nucleus accumbens (NAc) pathway plays a critical role in reward processing and possibly compulsive responses [<xref ref-type="bibr" rid="CR44">44</xref>]. Stein and Lochner have illustrated that the role of structures related to learning and reward include dopaminergic agonists in OCD [<xref ref-type="bibr" rid="CR45">45</xref>]. Terrillion et al. have also reported that decreased expression of the <italic>CACNA1C</italic> gene in the mesolimbic pathway reduces mania symptoms [<xref ref-type="bibr" rid="CR46">46</xref>].</p>
<p id="Par30">Besides, GRIA1 encodes glutamate receptor, ionotropic, AMPA1, which acts as an excitatory glutamate receptor in the central nervous system. Evidence has suggested that AMPA1 gene is associated with impaired working memory and reward processing in patients with OCD [<xref ref-type="bibr" rid="CR47">47</xref>]. OCD has been conceptualized as a behavioral addiction with defective processing in reward circuity [<xref ref-type="bibr" rid="CR48">48</xref>]. Compulsions act as a reward, suppressing the anxiety-provoking obsessions [<xref ref-type="bibr" rid="CR49">49</xref>]. Also, studies have reported that GRIA1 may regulate the circadian rhythms, through the regulation of <italic>Clock</italic> gene, which has been demonstrated to be disrupted in the ventral tegmental area of patients with BD, particularly in manic episodes [<xref ref-type="bibr" rid="CR50">50</xref>–<xref ref-type="bibr" rid="CR52">52</xref>].</p>
<p id="Par31">DRDR2 is one of the other prominent genes in this collection. The interface between obsessive–compulsive and bipolar disorders can be explained through the concept of “reward deficiency syndrome (RDS)” [<xref ref-type="bibr" rid="CR53">53</xref>]. The reward deficiency hypothesis proposes that aberrant functioning of normal reward pathways in one individual causes less satisfaction with natural rewards and enhance the inclination to compulsory use of substances or repetitive behaviors as a way to augment stimulation of the reward pathways [<xref ref-type="bibr" rid="CR54">54</xref>]. Blum et al. assume that addictive, impulsive and compulsive disorders may have a common genetic basis. They point to the role of genes involved in the dopaminergic system in this processes, among which DRD2 is the most determinant gene [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. A number of independent meta-analyses endorsed the association of DRD2 polymorphisms with RDS [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Impulsivity, has been known as a key intermediate phenotype in BD, which is present in inter-episode phases of the illness [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. This feature has also been recently taken into consideration in OCD [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. On the other hand, considering the frequent evidences about the risk of impulsivity in suicidal behaviors [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>], the presence of impulsivity might consider as a key predictor of suicidal attempts in both OCD and BD. Moreover, DRD2 is associated with learning the motor sequences [<xref ref-type="bibr" rid="CR65">65</xref>] and the motor components of several psychiatric disorders such as motor defects related to the first episode of psychosis [<xref ref-type="bibr" rid="CR66">66</xref>].</p>
<p id="Par32">In the present analysis, dopaminergic synapse as the most significant pathway and dopamine binding and dopamine neurotransmitter receptor activity, as two of the most significant molecular functions have been discovered. These findings point out to the major role of the dopaminergic system in both OCD and BD. Due to the wide-ranging and diverse functions assumed for dopamine, part of these functions supposed to be responsible for dysregulation in structures underlying symptoms of both OCD and BD. These symptoms are contradictory at the level of semiotics and phenotypes. The dopaminergic system and the neurotransmitter dopamine (DA) are responsible for many basic functions such as motivational and emotional behaviors, control of involuntary movements and neurosecretion associated with the biological clock and homeostatic sleep–wake regulation in humans [<xref ref-type="bibr" rid="CR67">67</xref>]. The DA system also has been known to be impaired in mechanisms involved in motor inhibition [<xref ref-type="bibr" rid="CR68">68</xref>] and cognitive functions in OCD [<xref ref-type="bibr" rid="CR69">69</xref>] and BD [<xref ref-type="bibr" rid="CR70">70</xref>]. Midbrain dopaminergic neurons in the mesocorticolimbic system regulate working memory, attention, decision-making and reward-associated behaviors. Bodea et al. reported that dopamine imbalances in the mesocorticolimbic pathway have been implicated in drug abuse, depression, attention deficit hyperactivity and schizophrenia disorders [<xref ref-type="bibr" rid="CR71">71</xref>].</p>
<p id="Par33">Suhara et al. reported that the dopamine-binding potentials in the frontal cortex of the patients with BD were significantly lower than normal controls. Also, Denys et al. demonstrated that the reduced binding potential of the dopamine D receptor, especially the D2 type receptor, is directly involved in the pathophysiology of OCD [<xref ref-type="bibr" rid="CR72">72</xref>].</p>
<p id="Par34">Reduced serotonergic activity in the forebrain regions contributes to the development of OCD [<xref ref-type="bibr" rid="CR73">73</xref>] and in the depression phase of BD [<xref ref-type="bibr" rid="CR74">74</xref>]. Defective inhibition of GABAergic system in the prefrontal cortex has been also shown in both BD [<xref ref-type="bibr" rid="CR75">75</xref>] and OCD [<xref ref-type="bibr" rid="CR76">76</xref>].</p>
<p id="Par35">Further analysis showed that cAMP signaling pathway is the most central pathway associated with the two disorders. It has been shown that the baseline receptor-mediated level of cAMP in plasma and cerebrospinal fluid is altered in various mood states, including BD and major depression [<xref ref-type="bibr" rid="CR77">77</xref>]. Perez et al. reported the altered cAMP-dependent kinase activity in platelets of patients with OCD [<xref ref-type="bibr" rid="CR78">78</xref>].</p>
<p id="Par36">Moreover, in his well-known hypothesis, Marazziti suggests that OCD is caused by a decreased activity of protein kinase type A (PKA), in the cAMP signaling pathway [<xref ref-type="bibr" rid="CR79">79</xref>]. In line with Marazziti, Tardito et al. argued that the cAMP-stimulated PKA activity is considerably increased in BD patients compared with healthy controls [<xref ref-type="bibr" rid="CR80">80</xref>] and cAMP-responsive element-binding (CREB)-1 gene (<italic>CREB1</italic>) is demonstrated to be associated with the risk of BD and obsessive behaviors [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>].</p>
<p id="Par37">On the other hand, transduction of the signal through metabotropic glutamate receptors [<xref ref-type="bibr" rid="CR83">83</xref>], dopamine receptors [<xref ref-type="bibr" rid="CR84">84</xref>], and 5-HT1, 4, 5, 6, and 7 receptors [<xref ref-type="bibr" rid="CR85">85</xref>] are mainly based on the cAMP-mediated cascades. Therefore, the defect in this signal processing system can also affect signal transduction through these receptors, as defects in the glutamatergic, serotonergic, GABAergic and dopaminergic neurotransmission systems in both OCD and BD have been identified [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR86">86</xref>–<xref ref-type="bibr" rid="CR88">88</xref>].</p>
<p id="Par38">Cellular component enrichment analysis revealed that the cellular components involved in receiving the signals, namely, dendrites, were the most important cellular components associated with OCD and BD. In this regard, Rosoklija et al. have indicated the structural abnormalities of dendrites in major mood disorders [<xref ref-type="bibr" rid="CR89">89</xref>] and Konopaske et al. have found that spine density is significantly reduced in the dorsolateral prefrontal cortex of BD subjects [<xref ref-type="bibr" rid="CR90">90</xref>].</p>
<p id="Par39">Finally, our analysis showed that the striatum is the most important brain region associated with obsessive–compulsive and bipolar disorders. Bipolar patients have been reported to show abnormal task-related activity in the striatum [<xref ref-type="bibr" rid="CR91">91</xref>] and substantial shape alterations in the anterior and ventral striatum [<xref ref-type="bibr" rid="CR92">92</xref>]. On the other hand, impaired working memory [<xref ref-type="bibr" rid="CR93">93</xref>], abnormal conditioning [<xref ref-type="bibr" rid="CR94">94</xref>], and decreased probabilistic learning [<xref ref-type="bibr" rid="CR95">95</xref>] are all known as striatum-dependent valuable endophenotypes for BD. Differences in volumes of the caudate nucleus and the putamen between OCD patients and healthy controls have been also reported??? [<xref ref-type="bibr" rid="CR96">96</xref>]. Moreover, functional imaging studies indicated the altered activities in the striatum of OCD patients, both during resting-state and during expression of symptoms [<xref ref-type="bibr" rid="CR97">97</xref>].</p>
<p id="Par40">Regarding clinical implications, studies of this kind may help in solving several issues clinicians usually face. If such gene-based infrastructured network is confirmed by future studies, it can be a determining factor in identifying individuals at risk among the siblings of the proband or predicting the risk of developing the disorder in the next generation. On the other hand, prognosis and disease prevention, a focus area for the mental healthcare systems, can be considered. In clinical settings, it is observed that some types of OCD patients tend to develop psychotic or manic symptoms. According to the results, those patients with defects in the most important identified components may be more susceptible to develop symptoms of the other serious illnesses, such as BD. Furthermore, finding more specific and effective drug therapies is the other implication of such findings. For example, in an OCD patient with disturbances in the above network, prescribing mood stabilizers, antipsychotics or other medications which target the identified genes, pathways or molecular functions in addition to SSRIs, may also be recommended prior to the appearance of mania symptoms at the phenotype level.</p>
</sec>
<sec id="Sec7">
<title>Conclusions</title>
<p id="Par41">Our analysis indicated <italic>CACNA1C</italic>, dopamine receptor binding activity, cAMP signaling pathway, dendrite and striatum as the most central gene, molecular function, pathway, cellular component and brain region, respectively, associated with both OCD and BD. Significantly all these elements are interconnected; in the striatal region, calcium receptor in dendrites may be affected by cAMP-mediated signaling pathways and affect the dopamine receptors, and this network may be the main impaired infrastructure associated with OCD and BD, although confirmation of this hypothesis requires comprehensive and integrated experimental studies in the future. Moreover, considering the functions of the most important genes, pathways, and molecular functions described in this study, it seems that several major functions including the reward processing, motor and cognitive functions such as memory can be pointed out as the most intermediate phenotypes shared between the two disorders. The results of the present study suggest that OCD–BD comorbidity caused by common genes and may occur with exposure to certain environmental factors. Accordingly, it can be assumed that the set of genes involved in the comorbidity of the disorder is different from the set of genes which are involved in the occurrence of each disorder alone. This finding should be further considered and taken into account during diagnoses and pharmacotherapy of the disorders. For example, in cases of comorbidity, it may be useful to prescribe drugs that are not the first line of treatment for either disorder when they occur alone. These findings might also be helpful in estimating the course of any disorder. Further studies could focus on explaining a more precise model of pathogenesis and the role of each component in developing co-occurrence.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec16">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12991_2020_280_MOESM1_ESM.xlsx"><caption><p><bold>Additional file 1.</bold> The name and references of the genes associated with OCD and BD.</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>OCD</term>
<def>
<p id="Par4">Obsessive–compulsive disorder</p>
</def>
</def-item>
<def-item>
<term>BD</term>
<def>
<p id="Par5">Bipolar disorder</p>
</def>
</def-item>
<def-item>
<term>GSEA</term>
<def>
<p id="Par6">Gene Set Enrichment Analysis</p>
</def>
</def-item>
<def-item>
<term>CSEA</term>
<def>
<p id="Par7">Cell Type-Specific Expression Analysis</p>
</def>
</def-item>
<def-item>
<term>GWASs</term>
<def>
<p id="Par8">Genome-wide association studies</p>
</def>
</def-item>
<def-item>
<term>DA</term>
<def>
<p id="Par9">Neurotransmitter dopamine</p>
</def>
</def-item>
<def-item>
<term>
<italic>CREB1</italic>
</term>
<def>
<p id="Par10">cAMP responsive element-binding (CREB)-1 gene</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher's Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s12991-020-00280-9.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>SH: contribution to design of the work, acquisition of data and analysis. AP: contribution to the conception and interpretation of data. AB: contribution to design of the work, acquisition of data and analysis. ESA: contribution to conception, designing the work and interpretation of data. BD: acquisition of data. MO: acquisition of data. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>Not applicable.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>All data analyzed during this study are included in this manuscript and its additional file. The detailed data like the articles from which the data were extracted are available through their references mentioned in additional file or contacting the corresponding author.</p>
</notes>
<notes id="FPar1">
<title>Ethics approval and consent to participate</title>
<p id="Par42">Not applicable.</p>
</notes>
<notes id="FPar2">
<title>Consent for publication</title>
<p id="Par43">Not applicable.</p>
</notes>
<notes id="FPar3" notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par44">The authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonçalves</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>224. Examining mitochondrial genetic dysfunction in obsessive compulsive disorder</article-title>
<source/>Biol Psychiatry.
          <year>2017</year>
<volume>81</volume>
<issue>10</issue>
<fpage>S92</fpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2017.02.237</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinopoli</surname>
<given-names>VM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A review of the role of serotonin system genes in obsessive–compulsive disorder</article-title>
<source/>Neurosci Biobehav Rev
          <year>2017</year>
<volume>80</volume>
<fpage>372</fpage>
<lpage>381</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2017.05.029</pub-id>
<pub-id pub-id-type="pmid">28576508</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noh</surname>
<given-names>HJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Integrating evolutionary and regulatory information with a multispecies approach implicates genes and pathways in obsessive–compulsive disorder</article-title>
<source/>Nat Commun
          <year>2017</year>
<volume>8</volume>
<issue>1</issue>
<fpage>774</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-017-00831-x</pub-id>
<pub-id pub-id-type="pmid">29042551</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>DL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive–compulsive disorder as an example of overlapping clinical and genetic heterogeneity</article-title>
<source/>Philos Trans R Soc B
          <year>2013</year>
<volume>368</volume>
<issue>1615</issue>
<fpage>20120435</fpage>
<pub-id pub-id-type="doi">10.1098/rstb.2012.0435</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LaSalle</surname>
<given-names>VH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnostic interview assessed neuropsychiatric disorder comorbidity in 334 individuals with obsessive–compulsive disorder</article-title>
<source/>Depress Anxiety
          <year>2004</year>
<volume>19</volume>
<issue>3</issue>
<fpage>163</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="doi">10.1002/da.20009</pub-id>
<pub-id pub-id-type="pmid">15129418</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Timpano</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Rubenstein</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>Phenomenological features and clinical impact of affective disorders in OCD: a focus on the bipolar disorder and OCD connection</article-title>
<source/>Depress Anxiety
          <year>2012</year>
<volume>29</volume>
<issue>3</issue>
<fpage>226</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1002/da.20908</pub-id>
<pub-id pub-id-type="pmid">22109969</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Ambrosio</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Obsessive–compulsive disorder and cyclothymic temperament: an exploration of clinical features</article-title>
<source/>J Affect Disord
          <year>2010</year>
<volume>127</volume>
<issue>1</issue>
<fpage>295</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2010.06.007</pub-id>
<pub-id pub-id-type="pmid">20591494</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amerio</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnostic validity of comorbid bipolar disorder and obsessive–compulsive disorder: a systematic review</article-title>
<source/>Acta Psychiatr Scand
          <year>2014</year>
<volume>129</volume>
<issue>5</issue>
<fpage>343</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="doi">10.1111/acps.12250</pub-id>
<pub-id pub-id-type="pmid">24506190</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vázquez</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Baldessarini</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Tondo</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Co-occurrence of anxiety and bipolar disorders: clinical and therapeutic overview</article-title>
<source/>Depress Anxiety
          <year>2014</year>
<volume>31</volume>
<issue>3</issue>
<fpage>196</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1002/da.22248</pub-id>
<pub-id pub-id-type="pmid">24610817</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amerio</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Course of illness in comorbid bipolar disorder and obsessive–compulsive disorder patients</article-title>
<source/>Asian J Psychiatry
          <year>2016</year>
<volume>20</volume>
<fpage>12</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajp.2016.01.009</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joshi</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical characteristics of comorbid obsessive–compulsive disorder and bipolar disorder in children and adolescents</article-title>
<source/>Bipolar Disord
          <year>2010</year>
<volume>12</volume>
<issue>2</issue>
<fpage>185</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-5618.2010.00795.x</pub-id>
<pub-id pub-id-type="pmid">20402711</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghio</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Duration of untreated depression influences clinical outcomes and disability</article-title>
<source/>J Affect Disord
          <year>2015</year>
<volume>175</volume>
<fpage>224</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2015.01.014</pub-id>
<pub-id pub-id-type="pmid">25658495</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Mallakh</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Hollifield</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Comorbid anxiety in bipolar disorder alters treatment and prognosis</article-title>
<source/>Psychiatr Q
          <year>2008</year>
<volume>79</volume>
<issue>2</issue>
<fpage>139</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1007/s11126-008-9071-5</pub-id>
<pub-id pub-id-type="pmid">18491230</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nestadt</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The relationship between obsessive–compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study</article-title>
<source/>Psychol Med
          <year>2001</year>
<volume>31</volume>
<issue>3</issue>
<fpage>481</fpage>
<lpage>487</lpage>
<pub-id pub-id-type="doi">10.1017/S0033291701003579</pub-id>
<pub-id pub-id-type="pmid">11305856</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berutti</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between family history of mood disorders and clinical characteristics of bipolar disorder: results from the Brazilian bipolar research network</article-title>
<source/>J Affect Disord
          <year>2014</year>
<volume>161</volume>
<fpage>104</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2014.02.045</pub-id>
<pub-id pub-id-type="pmid">24751316</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cederlöf</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Obsessive–compulsive disorder, psychosis, and bipolarity: a longitudinal cohort and multigenerational family study</article-title>
<source/>Schizophr Bull
          <year>2014</year>
<volume>41</volume>
<issue>5</issue>
<fpage>1076</fpage>
<lpage>1083</lpage>
<pub-id pub-id-type="doi">10.1093/schbul/sbu169</pub-id>
<pub-id pub-id-type="pmid">25512596</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deckersbach</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Episodic memory impairment in bipolar disorder and obsessive–compulsive disorder: the role of memory strategies</article-title>
<source/>Bipolar Disord
          <year>2004</year>
<volume>6</volume>
<issue>3</issue>
<fpage>233</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-5618.2004.00118.x</pub-id>
<pub-id pub-id-type="pmid">15117402</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penades</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired response inhibition in obsessive compulsive disorder</article-title>
<source/>Eur Psychiatry
          <year>2007</year>
<volume>22</volume>
<issue>6</issue>
<fpage>404</fpage>
<lpage>410</lpage>
<pub-id pub-id-type="doi">10.1016/j.eurpsy.2006.05.001</pub-id>
<pub-id pub-id-type="pmid">17127038</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lennertz</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Antisaccade performance in patients with obsessive–compulsive disorder and unaffected relatives: further evidence for impaired response inhibition as a candidate endophenotype</article-title>
<source/>Eur Arch Psychiatry Clin Neurosci
          <year>2012</year>
<volume>262</volume>
<issue>7</issue>
<fpage>625</fpage>
<lpage>634</lpage>
<pub-id pub-id-type="doi">10.1007/s00406-012-0311-1</pub-id>
<pub-id pub-id-type="pmid">22437321</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norman</surname>
<given-names>LJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Shared and disorder-specific task-positive and default mode network dysfunctions during sustained attention in paediatric Attention-Deficit/Hyperactivity Disorder and obsessive/compulsive disorder</article-title>
<source/>NeuroImage Clin.
          <year>2017</year>
<volume>15</volume>
<fpage>181</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1016/j.nicl.2017.04.013</pub-id>
<pub-id pub-id-type="pmid">28529874</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bora</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yucel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pantelis</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives</article-title>
<source/>J Affect Disord
          <year>2009</year>
<volume>113</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2008.06.009</pub-id>
<pub-id pub-id-type="pmid">18684514</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benatti</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterizing impulsivity profile in patients with obsessive–compulsive disorder</article-title>
<source/>Int J Psychiatry Clin Pract
          <year>2014</year>
<volume>18</volume>
<issue>3</issue>
<fpage>156</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.3109/13651501.2013.855792</pub-id>
<pub-id pub-id-type="pmid">24151922</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>TH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impulsivity predicts the onset of DSM-IV-TR or RDC hypomanic and manic episodes in adolescents and young adults with high or moderate reward sensitivity</article-title>
<source/>J Affect Disord
          <year>2016</year>
<volume>198</volume>
<fpage>88</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2016.03.045</pub-id>
<pub-id pub-id-type="pmid">27011364</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozdemiroglu</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comorbid obsessive–compulsive disorder with bipolar disorder: a distinct form?</article-title>
<source/>Psychiatry Res
          <year>2015</year>
<volume>230</volume>
<issue>3</issue>
<fpage>800</fpage>
<lpage>805</lpage>
<pub-id pub-id-type="doi">10.1016/j.psychres.2015.11.002</pub-id>
<pub-id pub-id-type="pmid">26561371</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Najt</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impulsivity and bipolar disorder</article-title>
<source/>Eur Neuropsychopharmacol
          <year>2007</year>
<volume>17</volume>
<issue>5</issue>
<fpage>313</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="doi">10.1016/j.euroneuro.2006.10.002</pub-id>
<pub-id pub-id-type="pmid">17140772</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adida</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Trait-related decision-making impairment in the three phases of bipolar disorder</article-title>
<source/>Biol Psychiatry
          <year>2011</year>
<volume>70</volume>
<issue>4</issue>
<fpage>357</fpage>
<lpage>365</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2011.01.018</pub-id>
<pub-id pub-id-type="pmid">21429477</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grassi</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Think twice: impulsivity and decision making in obsessive–compulsive disorder</article-title>
<source/>J Behav Addict
          <year>2015</year>
<volume>4</volume>
<issue>4</issue>
<fpage>263</fpage>
<lpage>272</lpage>
<pub-id pub-id-type="doi">10.1556/2006.4.2015.039</pub-id>
<pub-id pub-id-type="pmid">26690621</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tonna</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Are obsessive–compulsive symptoms expression of vulnerability to bipolar disorder?</article-title>
<source/>Acta Psychiatr Scand
          <year>2015</year>
<volume>132</volume>
<issue>5</issue>
<fpage>411</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="doi">10.1111/acps.12481</pub-id>
<pub-id pub-id-type="pmid">26366745</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakao</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kanba</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Neurobiological model of obsessive–compulsive disorder: evidence from recent neuropsychological and neuroimaging findings</article-title>
<source/>Psychiatry Clin Neurosci
          <year>2014</year>
<volume>68</volume>
<issue>8</issue>
<fpage>587</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="doi">10.1111/pcn.12195</pub-id>
<pub-id pub-id-type="pmid">24762196</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<mixed-citation publication-type="other">Tseng W-L, Leibenluft E, Brotman MA. A systems neuroscience approach to the pathophysiology of pediatric mood and anxiety disorders. In: The neurobiology of childhood. 2013; Berlin: Springer. p. 297–317.</mixed-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deckersbach</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dougherty</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Rauch</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Functional imaging of mood and anxiety disorders</article-title>
<source/>J Neuroimaging
          <year>2006</year>
<volume>16</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1177/1051228405001474</pub-id>
<pub-id pub-id-type="pmid">16483270</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stahl</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomewide association study identifies 30 loci associated with bipolar disorder</article-title>
<source/>bioRxiv
          <year>2017</year>
<volume>51</volume>
<issue>5</issue>
<fpage>793</fpage>
<lpage>803</lpage>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bozorgmehr</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ghadirivasfi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shahsavand</surname>
<given-names>Ananloo E</given-names>
</name>
</person-group>
<article-title>Obsessive–compulsive disorder, which genes? Which functions? Which pathways? An integrated holistic view regarding OCD and its complex genetic etiology</article-title>
<source/>J Neurogenet.
          <year>2017</year>
<volume>31</volume>
<issue>3</issue>
<fpage>53</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.1080/01677063.2017.1336236</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomes</surname>
<given-names>CKF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association analysis of SLC6A4 and HTR2A genes with obsessive–compulsive disorder: influence of the STin2 polymorphism</article-title>
<source/>Compr Psychiatry
          <year>2018</year>
<volume>82</volume>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/j.comppsych.2017.12.004</pub-id>
<pub-id pub-id-type="pmid">29331882</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnett</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Smoller</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>The genetics of bipolar disorder</article-title>
<source/>Neuroscience
          <year>2009</year>
<volume>164</volume>
<issue>1</issue>
<fpage>331</fpage>
<lpage>343</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.03.080</pub-id>
<pub-id pub-id-type="pmid">19358880</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Connell</surname>
<given-names>KS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The genetic architecture of schizophrenia, bipolar disorder, obsessive–compulsive disorder and autism spectrum disorder</article-title>
<source/>Mol Cell Neurosci
          <year>2018</year>
<volume>88</volume>
<fpage>300</fpage>
<lpage>307</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2018.02.010</pub-id>
<pub-id pub-id-type="pmid">29505902</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<mixed-citation publication-type="other">Privitera A. et al. OCDB: the first overall database collecting genes, miRNAs and drugs for obsessive–compulsive disorder. 2016, University of Verona 2016.</mixed-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<mixed-citation publication-type="other">Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. 1995–2019. Kyoto University.</mixed-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit</article-title>
<source/>Nucleic Acids Res.
          <year>2017</year>
<volume>45</volume>
<issue>W1</issue>
<fpage>W130</fpage>
<lpage>W137</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkx356</pub-id>
<pub-id pub-id-type="pmid">28472511</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhat</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease</article-title>
<source/>Prog Neurobiol.
          <year>2012</year>
<volume>99</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1016/j.pneurobio.2012.06.001</pub-id>
<pub-id pub-id-type="pmid">22705413</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kabir</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rajadhyaksha</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>L-type Ca<sup>2+</sup> channels in mood, cognition and addiction: integrating human and rodent studies with a focus on behavioural endophenotypes</article-title>
<source/>J Physiol
          <year>2016</year>
<volume>594</volume>
<issue>20</issue>
<fpage>5823</fpage>
<lpage>5837</lpage>
<pub-id pub-id-type="doi">10.1113/JP270673</pub-id>
<pub-id pub-id-type="pmid">26913808</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krug</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A genome-wide supported variant in CACNA1C influences hippocampal activation during episodic memory encoding and retrieval</article-title>
<source/>Eur Arch Psychiatry Clin Neurosci
          <year>2014</year>
<volume>264</volume>
<issue>2</issue>
<fpage>103</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.1007/s00406-013-0428-x</pub-id>
<pub-id pub-id-type="pmid">23860750</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lancaster</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CACNA1C risk variant affects reward responsiveness in healthy individuals</article-title>
<source/>Transl Psychiatry
          <year>2014</year>
<volume>4</volume>
<issue>10</issue>
<fpage>e461</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2014.100</pub-id>
<pub-id pub-id-type="pmid">25290268</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nestler</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Carlezon</surname>
<given-names>WA</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>The mesolimbic dopamine reward circuit in depression</article-title>
<source/>Biol Psychiat
          <year>2006</year>
<volume>59</volume>
<issue>12</issue>
<fpage>1151</fpage>
<lpage>1159</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2005.09.018</pub-id>
<pub-id pub-id-type="pmid">16566899</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huey</surname>
<given-names>ED</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A psychological and neuroanatomical model of obsessive–compulsive disorder</article-title>
<source/>J Neuropsychiat Clin Neurosci
          <year>2008</year>
<volume>20</volume>
<issue>4</issue>
<fpage>390</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="doi">10.1176/jnp.2008.20.4.390</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terrillion</surname>
<given-names>CE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduced levels of C acna1c attenuate mesolimbic dopamine system function</article-title>
<source/>Genes Brain Behav
          <year>2017</year>
<volume>16</volume>
<issue>5</issue>
<fpage>495</fpage>
<lpage>505</lpage>
<pub-id pub-id-type="doi">10.1111/gbb.12371</pub-id>
<pub-id pub-id-type="pmid">28186690</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kerner</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder</article-title>
<source/>Am J Med Genet Part B Neuropsychiat Genet
          <year>2009</year>
<volume>150</volume>
<issue>1</issue>
<fpage>24</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30780</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Figee</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysfunctional reward circuitry in obsessive–compulsive disorder</article-title>
<source/>Biol Psychiat
          <year>2011</year>
<volume>69</volume>
<issue>9</issue>
<fpage>867</fpage>
<lpage>874</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.12.003</pub-id>
<pub-id pub-id-type="pmid">21272861</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Figee</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Compulsivity in obsessive–compulsive disorder and addictions</article-title>
<source/>Eur Neuropsychopharmacol
          <year>2016</year>
<volume>26</volume>
<issue>5</issue>
<fpage>856</fpage>
<lpage>868</lpage>
<pub-id pub-id-type="doi">10.1016/j.euroneuro.2015.12.003</pub-id>
<pub-id pub-id-type="pmid">26774279</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukherjee</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Knockdown of Clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior</article-title>
<source/>Biol Psychiat
          <year>2010</year>
<volume>68</volume>
<issue>6</issue>
<fpage>503</fpage>
<lpage>511</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.04.031</pub-id>
<pub-id pub-id-type="pmid">20591414</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parekh</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Ozburn</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>McClung</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Circadian clock genes: effects on dopamine, reward and addiction</article-title>
<source/>Alcohol
          <year>2015</year>
<volume>49</volume>
<issue>4</issue>
<fpage>341</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1016/j.alcohol.2014.09.034</pub-id>
<pub-id pub-id-type="pmid">25641765</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parekh</surname>
<given-names>PK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered GluA1 (Gria1) function and accumbal synaptic plasticity in the ClockΔ19 model of bipolar mania</article-title>
<source/>Biol Psychiatry
          <year>2017</year>
<volume>84</volume>
<issue>11</issue>
<fpage>817</fpage>
<lpage>826</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2017.06.022</pub-id>
<pub-id pub-id-type="pmid">28780133</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blum</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reward deficiency syndrome</article-title>
<source/>Am Sci
          <year>1996</year>
<volume>84</volume>
<issue>2</issue>
<fpage>132</fpage>
<lpage>145</lpage>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<mixed-citation publication-type="other">Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. In: Progress in brain research. Amsterdam: Elsevier; 2000. p. 325–41.</mixed-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blum</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive and compulsive behaviors</article-title>
<source/>J Psychoact Drugs
          <year>2000</year>
<volume>32</volume>
<issue>sup1</issue>
<fpage>1</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1080/02791072.2000.10736099</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blum</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land?</article-title>
<source/>Expert Opin Biol Therapy
          <year>2015</year>
<volume>15</volume>
<issue>7</issue>
<fpage>973</fpage>
<lpage>985</lpage>
<pub-id pub-id-type="doi">10.1517/14712598.2015.1045871</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blum</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dopamine D2 receptor gene variants: association and linkage studies in impulsive–addictive–compulsive behaviour</article-title>
<source/>Pharmacogenetics
          <year>1995</year>
<volume>5</volume>
<issue>3</issue>
<fpage>121</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="doi">10.1097/00008571-199506000-00001</pub-id>
<pub-id pub-id-type="pmid">7550364</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Febo</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome</article-title>
<source/>Front Biosci
          <year>2017</year>
<volume>22</volume>
<fpage>669</fpage>
<lpage>691</lpage>
<pub-id pub-id-type="doi">10.2741/4509</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swann</surname>
<given-names>AC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impulsivity: a link between bipolar disorder and substance abuse</article-title>
<source/>Bipolar Disord
          <year>2004</year>
<volume>6</volume>
<issue>3</issue>
<fpage>204</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-5618.2004.00110.x</pub-id>
<pub-id pub-id-type="pmid">15117399</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swann</surname>
<given-names>AC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impulsivity and phase of illness in bipolar disorder</article-title>
<source/>J Affect Disord
          <year>2003</year>
<volume>73</volume>
<issue>1</issue>
<fpage>105</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-0327(02)00328-2</pub-id>
<pub-id pub-id-type="pmid">12507743</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parkes</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transdiagnostic variations in impulsivity and compulsivity in obsessive–compulsive disorder and gambling disorder correlate with effective connectivity in cortical-striatal-thalamic-cortical circuits</article-title>
<source/>bioRxiv
          <year>2018</year>
<volume>202</volume>
<fpage>389320</fpage>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martoni</surname>
<given-names>RM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Planning functioning and impulsiveness in obsessive–compulsive disorder</article-title>
<source/>Eur Arch Psychiatry Clin Neurosci
          <year>2018</year>
<volume>268</volume>
<issue>5</issue>
<fpage>471</fpage>
<lpage>481</lpage>
<pub-id pub-id-type="doi">10.1007/s00406-017-0803-0</pub-id>
<pub-id pub-id-type="pmid">28466133</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coryell</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Aggression, impulsivity and inflammatory markers as risk factors for suicidal behavior</article-title>
<source/>J Psychiatr Res
          <year>2018</year>
<volume>106</volume>
<fpage>38</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2018.09.004</pub-id>
<pub-id pub-id-type="pmid">30261413</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valderrama</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Miranda</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jeglic</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Ruminative subtypes and impulsivity in risk for suicidal behavior</article-title>
<source/>Psychiatry Res
          <year>2016</year>
<volume>236</volume>
<fpage>15</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1016/j.psychres.2016.01.008</pub-id>
<pub-id pub-id-type="pmid">26791398</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baetu</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Commonly-occurring polymorphisms in the COMT, DRD1 and DRD2 genes influence different aspects of motor sequence learning in humans</article-title>
<source/>Neurobiol Learn Mem
          <year>2015</year>
<volume>125</volume>
<fpage>176</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1016/j.nlm.2015.09.009</pub-id>
<pub-id pub-id-type="pmid">26419600</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lencer</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of variants in DRD2 and GRM3 with motor and cognitive function in first-episode psychosis</article-title>
<source/>Eur Arch Psychiatry Clin Neurosci
          <year>2014</year>
<volume>264</volume>
<issue>4</issue>
<fpage>345</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="doi">10.1007/s00406-013-0464-6</pub-id>
<pub-id pub-id-type="pmid">24682224</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krzymowski</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Stefanczyk-Krzymowska</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>New facts and the concept of physiological regulation of the dopaminergic system function and its disorders</article-title>
<source/>J Physiol Pharmacol
          <year>2015</year>
<volume>66</volume>
<issue>3</issue>
<fpage>331</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="pmid">26084215</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Velzen</surname>
<given-names>LS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Response inhibition and interference control in obsessive–compulsive spectrum disorders</article-title>
<source/>Front Hum Neurosci
          <year>2014</year>
<volume>8</volume>
<fpage>419</fpage>
<pub-id pub-id-type="pmid">24966828</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tükel</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>COMT Val158Met polymorphism and executive functions in obsessive–compulsive disorder</article-title>
<source/>J Neuropsychiat Clin Neurosci
          <year>2013</year>
<volume>25</volume>
<issue>3</issue>
<fpage>214</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1176/appi.neuropsych.12040103</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cousins</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Butts</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>The role of dopamine in bipolar disorder</article-title>
<source/>Bipolar Disord
          <year>2009</year>
<volume>11</volume>
<issue>8</issue>
<fpage>787</fpage>
<lpage>806</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-5618.2009.00760.x</pub-id>
<pub-id pub-id-type="pmid">19922550</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bodea</surname>
<given-names>GO</given-names>
</name>
<name>
<surname>Blaess</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Establishing diversity in the dopaminergic system</article-title>
<source/>FEBS Lett
          <year>2015</year>
<volume>589</volume>
<issue>24</issue>
<fpage>3773</fpage>
<lpage>3785</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2015.09.016</pub-id>
<pub-id pub-id-type="pmid">26431946</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denys</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Low level of dopaminergic D2 receptor binding in obsessive–compulsive disorder</article-title>
<source/>Biol Psychiatry
          <year>2004</year>
<volume>55</volume>
<issue>10</issue>
<fpage>1041</fpage>
<lpage>1045</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2004.01.023</pub-id>
<pub-id pub-id-type="pmid">15121489</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Insel</surname>
<given-names>TR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Obsessive–compulsive disorder and serotonin: is there a connection?</article-title>
<source/>Biol Psychiat
          <year>1985</year>
<volume>20</volume>
<issue>11</issue>
<fpage>1174</fpage>
<lpage>1188</lpage>
<pub-id pub-id-type="doi">10.1016/0006-3223(85)90176-3</pub-id>
<pub-id pub-id-type="pmid">2413912</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahmood</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Silverstone</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Serotonin and bipolar disorder</article-title>
<source/>J Affect Disord
          <year>2001</year>
<volume>66</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-0327(00)00226-3</pub-id>
<pub-id pub-id-type="pmid">11532527</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanaka</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Dysfunctional GABAergic inhibition in the prefrontal cortex leading to “psychotic” hyperactivation</article-title>
<source/>BMC Neurosci
          <year>2008</year>
<volume>9</volume>
<issue>1</issue>
<fpage>41</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2202-9-41</pub-id>
<pub-id pub-id-type="pmid">18439259</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain gamma-aminobutyric acid (GABA) concentration of the prefrontal lobe in unmedicated patients with obsessive–compulsive disorder: a research of magnetic resonance spectroscopy</article-title>
<source/>Shanghai Archiv Psychiatry
          <year>2016</year>
<volume>28</volume>
<issue>5</issue>
<fpage>263</fpage>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dwivedi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>GN</given-names>
</name>
</person-group>
<article-title>Adenylyl cyclase-cyclicAMP signaling in mood disorders: Role of the crucial phosphorylating enzyme protein kinase A</article-title>
<source/>Neuropsychiat Dis Treat
          <year>2008</year>
<volume>4</volume>
<issue>1</issue>
<fpage>161</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.2147/NDT.S2380</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered cAMP-dependent protein kinase A in platelets of patients with obsessive–compulsive disorder</article-title>
<source/>Am J Psychiatry
          <year>2000</year>
<volume>157</volume>
<issue>2</issue>
<fpage>284</fpage>
<lpage>286</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.157.2.284</pub-id>
<pub-id pub-id-type="pmid">10671404</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marazziti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Perez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cassano</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>Is obsessive–compulsive disorder caused by a second-messenger imbalance?</article-title>
<source/>CNS Spectr
          <year>2001</year>
<volume>6</volume>
<issue>3</issue>
<fpage>206</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="doi">10.1017/S1092852900008579</pub-id>
<pub-id pub-id-type="pmid">16951654</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tardito</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Protein kinase A activity in platelets from patients with bipolar disorder</article-title>
<source/>J Affect Disord
          <year>2003</year>
<volume>76</volume>
<issue>1–3</issue>
<fpage>249</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-0327(02)00065-4</pub-id>
<pub-id pub-id-type="pmid">12943955</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders</article-title>
<source/>Mol Psychiatry
          <year>2017</year>
<volume>23</volume>
<issue>9</issue>
<fpage>1957</fpage>
<lpage>1967</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2017.243</pub-id>
<pub-id pub-id-type="pmid">29158582</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunoreactivity of cAMP response element binding protein is not altered in the post-mortem cerebral cortex or cerebellum of alcoholics</article-title>
<source/>Alcohol Alcohol
          <year>2001</year>
<volume>36</volume>
<issue>1</issue>
<fpage>70</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1093/alcalc/36.1.70</pub-id>
<pub-id pub-id-type="pmid">11139419</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willard</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Koochekpour</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Glutamate, glutamate receptors, and downstream signaling pathways</article-title>
<source/>Int J Biol Sci
          <year>2013</year>
<volume>9</volume>
<issue>9</issue>
<fpage>948</fpage>
<lpage>959</lpage>
<pub-id pub-id-type="doi">10.7150/ijbs.6426</pub-id>
<pub-id pub-id-type="pmid">24155668</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellenbroek</surname>
<given-names>BA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alexander Rudolf Cools (1942–2013)</article-title>
<source/>Psychopharmacology
          <year>2014</year>
<volume>231</volume>
<issue>11</issue>
<fpage>2219</fpage>
<lpage>2222</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-014-3583-5</pub-id>
<pub-id pub-id-type="pmid">24770629</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berumen</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serotonin receptors in hippocampus</article-title>
<source/>Sci World J
          <year>2012</year>
<volume>2012</volume>
<fpage>823493</fpage>
<pub-id pub-id-type="doi">10.1100/2012/823493</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurotransmission and bipolar disorder: a systematic family-based association study</article-title>
<source/>Am J Med Genet Part B Neuropsychiat Genet.
          <year>2008</year>
<volume>147B</volume>
<issue>7</issue>
<fpage>1270</fpage>
<lpage>1277</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30769</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manji</surname>
<given-names>HK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The underlying neurobiology of bipolar disorder</article-title>
<source/>World Psychiatry
          <year>2003</year>
<volume>2</volume>
<issue>3</issue>
<fpage>136</fpage>
<lpage>146</lpage>
<pub-id pub-id-type="pmid">16946919</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ting</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Neurobiology of obsessive–compulsive disorder: insights into neural circuitry dysfunction through mouse genetics</article-title>
<source/>Curr Opin Neurobiol
          <year>2011</year>
<volume>21</volume>
<issue>6</issue>
<fpage>842</fpage>
<lpage>848</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2011.04.010</pub-id>
<pub-id pub-id-type="pmid">21605970</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosoklija</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: Preliminary findings</article-title>
<source/>Arch Gen Psychiatry
          <year>2000</year>
<volume>57</volume>
<issue>4</issue>
<fpage>349</fpage>
<lpage>356</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.57.4.349</pub-id>
<pub-id pub-id-type="pmid">10768696</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konopaske</surname>
<given-names>GT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder</article-title>
<source/>JAMA psychiatry
          <year>2014</year>
<volume>71</volume>
<issue>12</issue>
<fpage>1323</fpage>
<lpage>1331</lpage>
<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.1582</pub-id>
<pub-id pub-id-type="pmid">25271938</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Killgore</surname>
<given-names>WDS</given-names>
</name>
<name>
<surname>Gruber</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Yurgelun-Todd</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Abnormal cortico-striatal activity during fear perception in bipolar disorder</article-title>
<source/>NeuroReport
          <year>2008</year>
<volume>19</volume>
<issue>15</issue>
<fpage>1523</fpage>
<lpage>1527</lpage>
<pub-id pub-id-type="doi">10.1097/WNR.0b013e328310af58</pub-id>
<pub-id pub-id-type="pmid">18797310</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Basal ganglia shape alterations in bipolar disorder</article-title>
<source/>Am J Psychiatry
          <year>2006</year>
<volume>163</volume>
<issue>2</issue>
<fpage>276</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.163.2.276</pub-id>
<pub-id pub-id-type="pmid">16449482</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frydecka</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impairments of working memory in schizophrenia and bipolar disorder: the effect of history of psychotic symptoms and different aspects of cognitive task demands</article-title>
<source/>Front Behav Neurosci
          <year>2014</year>
<volume>8</volume>
<fpage>416</fpage>
<pub-id pub-id-type="doi">10.3389/fnbeh.2014.00416</pub-id>
<pub-id pub-id-type="pmid">25506320</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolbecker</surname>
<given-names>AR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Eyeblink conditioning anomalies in bipolar disorder suggest cerebellar dysfunction</article-title>
<source/>Bipolar Disord
          <year>2009</year>
<volume>11</volume>
<issue>1</issue>
<fpage>19</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-5618.2008.00642.x</pub-id>
<pub-id pub-id-type="pmid">19133963</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pizzagalli</surname>
<given-names>DA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward task</article-title>
<source/>Biol Psychiatry
          <year>2008</year>
<volume>64</volume>
<issue>2</issue>
<fpage>162</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2007.12.001</pub-id>
<pub-id pub-id-type="pmid">18242583</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Heuvel</surname>
<given-names>OA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The major symptom dimensions of obsessive–compulsive disorder are mediated by partially distinct neural systems</article-title>
<source/>Brain
          <year>2009</year>
<volume>132</volume>
<issue>Pt 4</issue>
<fpage>853</fpage>
<lpage>868</lpage>
<pub-id pub-id-type="pmid">18952675</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whiteside</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Port</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Abramowitz</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>A meta-analysis of functional neuroimaging in obsessive–compulsive disorder</article-title>
<source/>Psychiatry Res
          <year>2004</year>
<volume>132</volume>
<issue>1</issue>
<fpage>69</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="doi">10.1016/j.pscychresns.2004.07.001</pub-id>
<pub-id pub-id-type="pmid">15546704</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>